# Study of XL784 in Patients With Albuminuria Due to Diabetic Nephropathy

> **NCT00312780** · PHASE2 · COMPLETED · sponsor: **Symphony Evolution, Inc.** · enrollment: 125 (actual)

## Conditions studied

- Albuminuria
- Diabetic Nephropathy

## Interventions

- **DRUG:** XL784

## Key facts

- **NCT ID:** NCT00312780
- **Lead sponsor:** Symphony Evolution, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** 2007-10
- **Final completion:** 2007-12
- **Target enrollment:** 125 (ACTUAL)
- **Last updated:** 2010-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00312780

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00312780, "Study of XL784 in Patients With Albuminuria Due to Diabetic Nephropathy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00312780. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*